Gene · 5732
Papers3,629
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,629
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rice-produced classical swine fever virus glycoprotein E2 with herringbone-dimer design to enhance immune responses. | Plant Biotechnol J | 2023 | 37572354 | PubTator, text mining | PubMed |
| Cyclooxygenase and Cancer: Fundamental Molecular Investigations. | Int J Mol Sci | 2023 | 37569718 | PubTator, text mining | PubMed |
| A novel classifier combining G protein-coupled receptors and the tumor microenvironment is associated with survival status in glioblastoma. | Front Pharmacol | 2023 | 37560473 | PubTator, text mining | PubMed |
| Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors. | Cancer Res Commun | 2023 | 37559947 | PubTator, text mining | PubMed |
| MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response. | Cancer Commun (Lond) | 2023 | 37539769 | PubTator, text mining | PubMed |
| Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities. | Lipids Health Dis | 2023 | 37537607 | PubTator, text mining | PubMed |
| Evaluating the Usefulness and Ease of Use of a Next-Generation-Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals' Perceptions. | JMIR Hum Factors | 2023 | 37531173 | PubTator, text mining | PubMed |
| ATP-P2X7R-mediated microglia senescence aggravates retinal ganglion cell injury in chronic ocular hypertension. | J Neuroinflammation | 2023 | 37525172 | PubTator, text mining | PubMed |
| Design, Synthesis, and Application of Fluorescent Ligands Targeting the Intracellular Allosteric Binding Site of the CXC Chemokine Receptor 2. | J Med Chem | 2023 | 37523859 | PubTator, text mining | PubMed |
| Prorelaxant E-type Prostanoid Receptors Functionally Partition to Different Procontractile Receptors in Airway Smooth Muscle. | Am J Respir Cell Mol Biol | 2023 | 37523713 | PubTator, text mining | PubMed |
| Inhibitory effects of NSAID-conjugated SN-38 on the viability of A549 Non-small cell lung cancer cells. | Biochem Biophys Rep | 2023 | 37521373 | PubTator, text mining | PubMed |
| Assessing the human development aspects of CO, PM2.5, PM10, NOX, and SO2 in the United States. | Heliyon | 2023 | 37519740 | PubTator, text mining | PubMed |
Results of Induction of Labor with Prostaglandins E1 and E2 (The RIPE Study): A Real-World Data Analysis of Obstetrical Effectiveness and Clinical Outcomes of Pharmacological Induction of Labor with Vaginal Inserts. | Pharmaceuticals (Basel) | 2023 | 37513894 | PubTator, text mining | PubMed |
| Peptide-Based Vaccine against Breast Cancer: Recent Advances and Prospects. | Pharmaceuticals (Basel) | 2023 | 37513835 | PubTator, text mining | PubMed |
| Electrooxidation of Hypercoordinated Derivatives of Silicon and Reactivity of Their Electrogenerated Cation Radicals: 1-Substituted Silatranes. | Molecules | 2023 | 37513433 | PubTator, text mining | PubMed |
| The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment. | Molecules | 2023 | 37513375 | PubTator, text mining | PubMed |
| Pulmonary Hypertension in the Course of Interstitial Lung Diseases-A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy. | Diagnostics (Basel) | 2023 | 37510098 | PubTator, text mining | PubMed |
| Why Temporal Inference Stimulation May Fail in the Human Brain: A Pilot Research Study. | Biomedicines | 2023 | 37509455 | PubTator, text mining | PubMed |
| The Effects and Mechanisms of PBM Therapy in Accelerating Orthodontic Tooth Movement. | Biomolecules | 2023 | 37509176 | PubTator, text mining | PubMed |
| Pathomechanisms of Prenatally Programmed Adult Diseases. | Antioxidants (Basel) | 2023 | 37507894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5732/papers?page=14